Detection of metastases using circulating tumour DNA in uveal melanoma
Open Access
- 22 August 2023
- journal article
- research article
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 149 (16) , 14953-14963
Abstract
Background: Approximately 50% of uveal melanoma (UM) patients will develop metastatic disease depending on the genetic features of the primary tumour. Patients need 3–12 monthly scans, depending on their prognosis, which is costly and often non-specific. Circulating tumour DNA (ctDNA) quantification could serve as a test to detect and monitor patients for early signs of metastasis and therapeutic response.Methods: We assessed ctDNA as a biomarker in three distinct UM cohorts using droplet-digital PCR: (A) a retrospective analysis of primary UM patients to predict metastases; (B) a prospective analysis of UM patients after resolution of their primary tumour for early detection of metastases; and (C) monitoring treatment response in metastatic UM patients.Results: Cohort A: ctDNA levels were not associated with the development of metastases. Cohort B: ctDNA was detected in 17/25 (68%) with radiological diagnosis of metastases. ctDNA was the strongest predictor of overall survival in a multivariate analysis (HR = 15.8, 95% CI 1.7–151.2,p = 0.017). Cohort C: ctDNA monitoring of patients undergoing immunotherapy revealed a reduction in the levels of ctDNA in patients with combination immunotherapy.Conclusions: Our proof-of-concept study shows the biomarker feasibility potential of ctDNA monitoring in for the clinical management of uveal melanoma patients.Keywords
Funding Information
- Australian Melanoma Research Foundation
- Australian Vision Research
- Raine Medical Research Foundation
- Edith Cowan University
This publication has 35 references indexed in Scilit:
- Circulating tumour DNA predicts response to anti-PD1 antibodies in metastatic melanomaAnnals of Oncology, 2017
- Circulating tumor DNA to monitor treatment response and detect acquired resistance in patients with metastatic melanomaOncotarget, 2015
- Survival from uveal melanoma in Western Australia 1981–2005Clinical & Experimental Ophthalmology, 2015
- Mutation profiling of tumor DNA from plasma and tumor tissue of colorectal cancer patients with a novel, high-sensitivity multiplexed mutation detection platformOncotarget, 2014
- Detection rate and prognostic value of circulating tumor cells and circulating tumor DNA in metastatic uveal melanomaInternational Journal of Cancer, 2013
- Surgical management of liver metastases from uveal melanoma: 16 years' experience at the Institut CurieEuropean Journal of Surgical Oncology, 2009
- Incidence of Uveal Melanoma in EuropeOphthalmology, 2007
- Development of Metastatic Disease After Enrollment in the COMS Trials for Treatment of Choroidal MelanomaArchives of Ophthalmology (1950), 2005
- Whole body PET/CT for initial staging of choroidal melanomaBritish Journal of Ophthalmology, 2005
- Very Long-Term Prognosis of Patients with Malignant Uveal MelanomaInvestigative Ophthalmology & Visual Science, 2003